BridgeBio Pharma, Inc.BBIONASDAQ

Revenue (LTM)

$502M

+126.3% YoY

Net Income (LTM)

$-729M

-36.1% YoY

Free Cash Flow

$-447M

Revenue CAGR (5Y)

+127.4%

Marginsdeclining

FCF($0.4B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	70	78↑11.4%	9↓88.0%	222↑2285.3%	502↑126.3%
Gross Profit	67	74↑11.4%	7↓90.8%	218↑3079.6%	474↑117.3%
Operating Income	-577	-512↑11.2%	-607↓18.6%	-593↑2.4%	-569↑4.0%
Net Income	-563	-481↑14.5%	-643↓33.7%	-536↑16.7%	-729↓36.1%
EBITDA	-534	-397↑25.5%	-565↓42.3%	-437↑22.7%	-673↓54.0%
EPS Diluted	-3.90	-3.35↑14.1%	-3.95↓17.9%	-2.88↑27.1%	-3.79↓31.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	394	377↓4.3%	376↓0.2%	681↑81.2%	570↓16.3%
Total Current Assets	889	549↓38.3%	478↓13.0%	721↑50.9%	754↑4.6%
Total Assets	1,013	623↓38.5%	546↓12.3%	919↑68.3%	936↑1.8%
Total Current Liabilities	135	121↓10.1%	144↑18.5%	154↑7.3%	288↑86.5%
Total Liabilities	1,878	1,868↓0.6%	1,889↑1.1%	2,377↑25.8%	3,013↑26.7%
Total Equity	-870	-1,255↓44.1%	-1,354↓7.9%	-1,468↓8.4%	-2,077↓41.5%
Total Debt	1,726	1,724↓0.2%	1,740↑0.9%	1,731↓0.5%	2,729↑57.7%
Net Debt	1,332	1,347↑1.1%	1,364↑1.3%	1,049↓23.1%	2,159↑105.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-498	-419↑15.8%	-528↓25.8%	-521↑1.3%	-446↑14.4%
Capital Expenditure	-48	-6↑86.9%	-1↑79.3%	-1↑28.6%	-1↓17.6%
Free Cash Flow	-546	-426↑22.0%	-529↓24.2%	-522↑1.4%	-447↑14.3%
Stock-Based Comp	100	92↓8.0%	0	96	133↑38.9%
Net Change in Cash	38	21↓45.6%	-22↓208.0%	289↑1402.4%	-111↓138.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance